Extracellular matrix and injured spinal cord tissue microenvironment (SCI microenvironment)

The extracellular matrix (ECM) and injured spinal cord tissue microenvironment represent the complex biochemical and physical milieu that develops following traumatic spinal cord injury (SCI). This environment is characterized by the formation of a glial scar, primarily composed of reactive astrocytes and inhibitory chondroitin sulfate proteoglycans (CSPGs), which serve as a significant barrier to axonal regeneration and functional recovery [1][3]. In addition to structural barriers, the microenvironment is saturated with myelin-associated inhibitors and pro-inflammatory cytokines that promote secondary cell death and prevent neural plasticity [2]. Targeting this environment is a major focus of regenerative medicine, utilizing strategies such as enzymatic digestion of the scar, antibody-mediated neutralization of inhibitors, and cell-based therapies to transform the inhibitory niche into a permissive one [4]. Understanding the temporal evolution of this microenvironment—from acute inflammation to chronic fibrosis—is critical for the timing and efficacy of therapeutic interventions [5].

Other names

Spinal cord injury nicheGlial scarFibrotic scarSCI lesion sitePerineuronal netsInhibitory extracellular matrix

Therapeutic approaches involve the enzymatic degradation of inhibitory chondroitin sulfate proteoglycans (CSPGs), neutralization of myelin-associated inhibitors (e.g., Nogo-A), modulation of the inflammatory cytokine profile to favor an M2 macrophage phenotype, and the introduction of biomaterial scaffolds to provide a permissive substrate for axonal regrowth [1][2].